Maryland TEDCO — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Phycinphycin.comJun 2024
Phycin develops engineered growth factors designed for higher stability and performance, including a thermostable recombinant basic fibroblast growth factor (bFGF) that remains active for 21+ days at 37°C.
BiotechLongevityMedical DevicesFrederick, US
Wang Jun(Executive Officer, Director)
Co-investorsTEDCO
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.